[Nuchal translucency measurement in early diagnosis of Down syndrome].
Saltvedt
S
S
Kvinnokliniken, Södersjukhuset, Stockholm.
Bui
T H
TH
D015415:Biomarkers / Q000097:blood; D003362:Cost-Benefit Analysis; D004314:Down Syndrome / Q000097:blood / Q000000981:diagnostic imaging* / Q000196:embryology; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D008423:Maternal Age; D009333:Neck / Q000000981:diagnostic imaging* / Q000196:embryology; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000009:adverse effects / Q000379:methods* / Q000523:psychology; D012307:Risk Factors; D016216:Ultrasonography, Prenatal / Q000009:adverse effects / Q000379:methods* / Q000523:psychology
D015415:Biomarkers